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Edited by Jesus AvilaAbstract The BKCa channel, a potassium channel that is
allosterically activated by voltage and calcium, is expressed in
both excitable and non-excitable cells. The channel plays an
important role in regulating membrane excitability. The channel
activity can be modulated by post-translational modiﬁcations
such as phosphorylation. Recently, hippocampal BKCa channels
were shown to be directly modulated by assembly/disassembly of
the submembranous actin cytoskeleton. Here, we report that the
BKCa channel physically interacts with the light chain of
microtubule associated protein 1A (MAP1A). The light chain
was isolated in a yeast two-hybrid screen of a human brain
cDNA library. The speciﬁcity of the interaction was demon-
strated in biochemical experiments utilizing GST fusion protein
pulldown assays and reciprocal co-immunoprecipitations from
rat brain. Furthermore, utilizing immunoﬂuorescence, the BKCa
channel and MAP1A co-localize in the Purkinje cell layer of the
cerebellum. These studies identify a novel interaction between the
C-terminal tail of the BKCa channel and the light chain of
MAP1A, which enables channel association with and modulation
by the cytoskeleton.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Calcium (Ca2þ) activated potassium (Kþ) channels are a
family of Kþ-selective ion channels that respond in an allo-
steric fashion to membrane voltage and intracellular Ca2þ
[1–5]. The large conductance voltage gated Kþ channels
(BKCa; Maxi K) channels are found in a large variety of ex-
citable and non-excitable cells [3]. In brain, BKCa channels are
localized to the cell bodies and nerve terminals [6]. In neurons,
the channels are partly responsible for the resetting of the
membrane potential after an action potential. In smooth
muscle, BKCa channels are responsible for hyperpolarizing
the membrane, thereby indirectly reducing contractility [7,8].* Corresponding author. Fax: +1-212-342-0475.
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extensively by alternative splicing, phosphorylation and asso-
ciated proteins, such as b subunits. The a subunit is composed
of 7 transmembrane segments, including a S4 voltage sensor
and P region to form the selectivity ﬁlter along with a long C-
terminus, which encompasses nearly 2/3 of the protein [9–12].
The C-terminus contains domains (Ca2þ bowl, regulator of
conductance of Kþ domain; RCK) [11,13,14] that are re-
sponsible for regulation by Ca2þ and Mg2þ, although a recent
report suggested that Ca2þ sensitivity can be maintained even
after C-terminus truncation [15]. However, C-terminal
truncation led to a markedly reduced surface expression of
the BKCa channel on the oocyte/HEK cell membrane, sug-
gesting that it might be involved in traﬃcking to the cell
membrane.
Emerging evidence suggests that ion channels can recruit
regulatory proteins, which can modulate their function [16,17].
BKCa channels are known to associate with b subunit, po-
tentially through the N-terminus, leading to speciﬁc regulation
of channel function [18–21]. In Drosophila, utilizing yeast two
hybrid screening, the C-terminus of dSlo was shown to be
associated with Slo binding protein (Slob) [22], which then
recruits 14–3–3 [23,24]. BKCa channels have also been shown
to associate with b 2 adrenergic receptor (b 2AR) in brain and
smooth muscle [25]. Thus, it is apparent that the BKCa
channel can form a macromolecular complex that can regulate
its activity. To identify novel BKCa binding partners, we
performed a yeast two hybrid screen of a rat brain cDNA li-
brary with a bait corresponding to the distal C-terminus of the
BKCa channel and isolated the light chain of the microtubule
associated protein 1A (MAP1A).
The function, localization and traﬃcking of many ion
channels can be regulated by their interaction with the cyto-
skeleton [26,27]. BKCa channels can be modulated by dynamic
assembly and disassembly of the submembranous actin cyto-
skeleton [28]. Disruption of actin ﬁlaments after brief treat-
ment with cytochalasin D markedly decreases the activity of
BKCa channels in brain [28], but increased channel activity in
rabbit coronary artery smooth muscle [29]. Microtubules and
their associated proteins are important determinants of neu-
ronal and non-neuronal cellular morphology and function [30].
High molecular weight microtubule associated proteins
(MAP), MAP1A and MAP2, form thin projections fromation of European Biochemical Societies.
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microtubules and cytoskeletal components [31]. MAP1B is
important for neurite formation in the developing brain [32],
whereas MAP1A may be required for neuronal maturation
and stabilization. The MAP1A mRNA encodes a heavy chain
(HC; 276 kDa) in frame with light chain 2 (LC2; 24 kDa). LC2
is cleaved from the MAP1A polyprotein and assembles non-
covalently with the N-terminal regions of the HC. The com-
ponents of a mature MAP1A consist of MAP1A HC, LC2,
LC3 (produced from a distinct single copy gene) and LC1 (27
kDa; cleaved from MAP1B).
We found that LC2 binds to the C-terminal region of BKCa
channels in vitro and in vivo, enabling the association of the
BKCa channels with MAP1A. Furthermore, we demonstrated
the co-localization of the BKCa channel in cerebellar Purkinje
cells. Our ﬁndings suggest that the BKCa channel–MAP1A
association may play an important role in BKCa localization
in brain and potentially other cellular systems.2. Materials and methods
2.1. Y2H assay
Yeast two hybrid cDNA library screening/analysis was performed
using the Matchmaker system as per the manufacturer’s instructions.
Rat BKCa C-terminal segment comprising of amino acid residues 746–
1144 (S9–S10 region) was subcloned in frame into DNA-BD/bait
vector (pGBKT7; Clontech) and transformed into AH109 strain. Lack
of auto-activation was conﬁrmed. The transformed AH109 were mated
with the Y187 strain, pre-transformed with AD vectors containing
human brain cDNA library inserts (Clontech). The mated strains were
screened, using SD/-Ade/-His/-Leu/-Trp in the presence of 3 lM 3-
amino-1,2,4-triazole, and positive clones were subsequently plated
onto X-a-Gal to detect a-galactosidase. Isolated clones were puriﬁed,
transformed into DH5a and sequenced.
2.2. GST fusion protein construction
BKCa C-terminus and MAP1A-LC2 cDNA digested from the
Clontech MATCHMAKER library AD vector were subcloned into
the pGEX-4T1 (Amersham) expression vector. Competent BL21 cells
were transformed with the above vectors, and GST-fusion protein
expression was induced using IPTG. BL21 were lysed with sonication
and fusion proteins were puriﬁed with glutathione sepharose beads
(Pharmacia Biotech). The isolated bead pellets were washed four times
with 1 ml phosphate buﬀer (PBS).
2.3. GST pulldowns
Rat brain lysates were homogenized in modiﬁed RIPA buﬀer con-
taining 1% Triton X-100 (v/v), 20 mM EDTA, 10 mM EGTA, 10 mM
Tris–HCl, pH 7.4+Complete Mini tablet (Roche), calpain I inhibitor,
calpain II inhibitor and PMSF. Insoluble material was removed by
centrifugation (20K RCF; 10 min, 2) and supernatants were col-
lected. Rat brain lysates were pre-cleared with glutathione beads for 20
min at 4 C. GST pulldowns were performed in 500 ll of immuno-
precipitation buﬀer [Tris–HCl (50 mM), pH 7.4, NaCl (50 mM), Triton
X-100 (0.25%), Complete Mini tablet, and PMSF] with pre-cleared rat
brain lysate (1 mg) for 3 h at 4 C. The beads were washed four times
with 1 ml RIPA buﬀer, heated to 95 C for 6 min in SDS sample buﬀer,
size-fractionated on SDS–PAGE and transferred to nitrocellulose
membrane. Membranes were incubated with BKCa (BD Transduction
Laboratories 611248) and MAP1A (Chemicon International) anti-
bodies, followed by detection with ECL (Amersham).
2.4. Immunoprecipitations
Immunoprecipitations were performed in 500 ll of Tris–HCl (50
mM), pH 7.4, NaCl (50 mM), Triton X-100 (0.25%), Complete Mini
tablet, and PMSF using 9 lg MAP1A antibody or 2 lg BKCa (Alo-
mone Laboratories APC-021) antibody overnight at 4 C. Immune
complexes were collected using protein A (Amersham) or G sepharose
(Sigma) for 1 h, followed by extensive washing with IP buﬀer (7). Allimmunoprecipitations included negative controls (preimmune, anti-
body alone). Blots were developed with the use of either ECL
(Amersham) or Supersignal detection (Pierce). Input represents 5% of
immunoprecipitation. In all cases, data shown are representatives of
three or more similar experiments.
2.5. Immunocytochemistry
Adult mice (Swiss Webster) were perfused with 4% paraformalde-
hyde (PFA) in 100 mM PBS, pH 7.4. The brains were postﬁxed in cold
4% PFA overnight, cryoprotected with 100 mM PBS containing 30%
sucrose for 24 h at 4 C and frozen in OCT (Tissue-Tek). Brain sections
(40 lm) were prepared on a cryostat microtome and collected on Su-
perfrost slides (Fisher). Sections were blocked in normal donkey serum
(5% PBS-Tx) and then incubated with a cocktail of primary antibodies
(anti-BKCa antibody (1:500; Alomone Laboratories; APC-107) and
anti-MAP1A antibody (1:1000)) for 48 h at 4 C. After washing, sec-
tions were incubated in a cocktail of donkey anti-mouse IgG conju-
gated with Alexa 488 (1:500, Molecular Probes), donkey anti-rabbit
conjugated with Cy3 (1:500, Jackson ImmunoResearch Laboratories)
and Toto 3 (1:1000, Molecular Probes) for 2 h at room temperature.
Images were acquired using a Carl–Zeiss confocal microscope. To
conﬁrm speciﬁc binding of antibodies, the binding was blocked with
corresponding excess antigen or absence of primary antibody (data not
shown).3. Results
To elucidate novel BKCa regulatory proteins in mamma-
lian cells, we sought to identify proteins that bound to the
C-terminal portion of the rat BKCa channel. Part or all of
the C-terminal tail of dSlo has been previously used as baits
in yeast two-hybrid screens, which identiﬁed two novel
proteins that interact with and modulate dSlo [22,33]. The C-
terminal tail of the rat BKCa cDNA (amino acid 746- C
terminus; Fig. 1A) placed in frame within pGBKT7 (Clon-
tech) was used as the bait to screen a human brain cDNA
library. We screened more than 6· 106 clones and obtained
ﬁve conﬁrmed positive clones, of which one was the C-
terminal region of MAP1A (LC2/MAP1A) (Fig. 1B). The
clone, representing the complete LC2 coding region, is highly
conserved from an evolutionary perspective. MAP1A/LC2 is
translated as a polyprotein precursor that is posttransla-
tionally modiﬁed to produce the N-terminal MAP1A and the
C-terminal LC2 proteins [30]. The speciﬁcity of the yeast
interaction was conﬁrmed in yeast with a series of mating
experiments utilizing the C-terminal BKCa bait and LC2
prey (Fig. 1C). Taken together, the data suggest that the
BKCa channel associates directly with LC2.
To independently conﬁrm the speciﬁcity of the BKCa
channel–LC2 interaction in mammalian cells, we performed
GST pull-down assays. A GST-C terminal BKCa channel fu-
sion protein was produced in BL21 Escherchia coli and bound
to glutathione–sepharose beads. Lysates from rat brain were
applied to the beads and after extensive washing, the proteins
eluted from the beads and size fractionated by SDS–PAGE,
transferred to nitrocellose and blotted with a speciﬁc LC2
antibody [32,34]. GST-C terminal BKCa channel fusion pro-
tein speciﬁcally interacted with LC2, whereas GST alone failed
to interact with LC2 (Fig. 2A). The interaction was also con-
ﬁrmed in reciprocal experiments, in which a GST fusion pro-
tein was produced containing the LC2 clone isolated in yeast
two-hybrid screening. The GST-LC2 fusion protein bound to
glutathione–sepharose beads was incubated with rat brain ly-
sate followed by extensive washing. The eluted proteins were
size-fractionated on SDS–PAGE, transferred to nitrocellulose
Fig. 1. C-terminus of BKCa channel is associated with LC2 of MAP1A. (A) Schematic representation of BKCa channel demonstrating the region (in
red) utilized as bait for yeast two hybrid screening of brain cDNA library. BKCa channel has 7 transmembrane regions, with a large C-terminus. (B)
Schematic of MAP1A protein, demonstrating the N-terminal heavy chain (HC) and C-terminal light chain (LC). The DNA sequence and amino acid
sequence (human) of prey isolated from yeast two hybrid screen. The underlined region represents the full-length LC2 coding region. (C) Yeast two
hybrid analysis of interaction between fusion proteins consisting of DNA binding domain and C-terminus of BKCa channel, Lam, or p53, and DNA
activation domain fusion protein and LC2 or T antigen. C-terminal BKCa channel mated with LC2 demonstrated growth on drop-out media and
+Gal staining, whereas mating with T antigen failed to elicit growth or Gal staining. LC-2 mating with Lam or p53 also yielded no growth or Gal
staining.
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protein speciﬁcally interacted with the BKCa channel, whereas
GST alone failed to interact with the BKCa channel (Fig. 2B).Taken together, these data conﬁrm the interaction between
LC2 and the BKCa channel, ﬁrst identiﬁed in yeast two-hybrid
screening.
Fig. 2. Speciﬁc interaction of C-terminal of BKCa channel and LC2.
GST fusion proteins were prepared for the C-terminus of BKCa
channel and LC-2 region of MAP1A recovered from yeast two hybrid
screen. Rat brain extracts were incubated with GST fusion proteins,
followed by extensive washing. (A) Immunoblot using LC2 speciﬁc
antibody demonstrates that GST-C terminal BKCa fusion protein can
speciﬁcally interact with LC2, whereas GST alone failed to co-pre-
cipitate LC2. Lower panel demonstrates immunoblot using GST an-
tibody, showing the amount of GST fusion protein used in pull-down
experiments. (B) Immunoblot (upper) using BKCa antibody demon-
strates that GST-LC2 can co-precipitate BKCa channel from rat brain
extract, whereas GST alone failed to co-precipitate LC2. Lower panel
demonstrates immunoblot using GST antibody, showing the amount
of GST fusion protein used in pulldown experiments.
Fig. 3. BKCa channel is associated with MAP1A in rat brain. (A)
MAP1A (upper) and BKCa (lower) immunoblot of BKCa and pre-
immune immunoprecipitations from rat brain. BKCa speciﬁcally as-
sociates with MAP1A. (B) BKCa immunoprecipitates of MAP1A and
pre-immune immunoprecipitations from rat brain. MAP1A speciﬁcally
associates with BKCa channel.
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in native tissue can recruit MAP1A heavy chain into the
macromolecular complex. BKCa channel was immunoprecip-
itated from rat brain lysate using a speciﬁc anti-BKCa anti-
body (Fig. 3A; lower panel), whereas pre-immune serum failed
to immunoprecipitate BKCa channel. MAP1A heavy chain
was co-immunoprecipitated with BKCa channel (Fig. 3A;
upper panel). In reciprocal experiments, MAP1A was immu-
noprecipitated from rat brain lysate using an anti-MAP1A
antibody, and the immunoprecipitate was analyzed for bound
BKCa channel. BKCa channel co-immunoprecipitated withFig. 4. BKCa channel and MAP1A are co-localized in adult mouse cerebella
adult mouse cerebellum, for BKCa (red) and MAP1A (green). BKCa and M
Purkinje cells. Nuclear staining was Toto3 (blue). Scale bar, 5 lM.MAP1A, whereas BKCa channel was not detected in pre-im-
mune serum precipitates. Taken together, the data conﬁrm the
association of the BKCa channel with the MAP1A macro-
molecular complex in vivo.
Cerebellar Purkinje cells demonstrate high levels of the
BKCa channel [6], although the precise functional role of the
channels in these neurons has not been clearly identiﬁed [35].
However, it has been proposed that BKCa channels regulate
the excitability of Purkinje cells by contributing to afterhy-
perpolarizations and perhaps by shaping individual action
potentials [35]. To conﬁrm the interaction of the BKCa
channel and MAP1A in vivo, we performed immunohisto-
chemistry in the cerebellum of adult mouse brain with speciﬁc
anti BKCa channel and MAP1A antibodies. We demonstrated
signiﬁcant co-distribution of MAP1A and BKCa channels in
cerebellar Purkinje cells (Fig. 4). Taken together with the yeast
two hybrid, GST pull-down, co-immunoprecipitation results,
these ﬁndings suggest that the BKCa channel and MAP1A/
LC2 form a macromolecular complex in vivo. Furthermore,
the ﬁndings provide a biochemical basis for the recent reports
[28] suggesting that the actin cytoskeleton serves to function-
ally regulate the BKCa channels in brain.4. Discussion
In the present study, we show that the BKCa channel is part
of a macromolecular complex that includes the light chain and
heavy chain of MAP1A. We initially identiﬁed this novel in-
teraction utilizing yeast two-hybrid screening of a human brain
cDNA library. The interaction was conﬁrmed utilizing GST
fusion protein co-precipitation assays and in vivo utilizing
co-immunoprecipitation and co-localization with immunohis-
tochemistry. This ﬁnding is consistent with recent work dem-
onstrating the critical role of ion channels/transporters
C-terminus in mediating interactions with proteins that regu-
late traﬃcking, and interactions with the cytoskeleton and
regulatory proteins.
MAP1A binds to microtubules [36,37] and microﬁlaments
[31,38,39]. In the brain, light chains can be found either as-
sociated with or not associated with the heavy chain of MAP1
[40]. MAP1 has been proposed to be involved in regulating the
interaction between axonal microtubules and actin ﬁlaments,
which is believed to be essential for neuronal morphogenesis
and function. Association of MAP1B with microtubules is
mediated by two unique microtubule binding domains located
on the heavy chain [41] and light chain [42,43]. Several regions
located in the heavy chain of MAP1A have also been suggested
to be responsible for the MAP1A association with microtu-
bules [44,45]. Despite the lack of homology between LC2 and
the microtubule binding domain of LC1, the N-terminus ofr Purkinje cells. Representative confocal images of immunostaining of
AP1A are co-localized/distributed (merged image) on the soma of the
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binds to cellular microtubules, but also stabilizes them in the
presence of colchicine. The LC2 N-terminus was necessary and
suﬃcient for microtubule binding and polymerization. The C-
terminus of LC1 can undergo dimerization/oligomerization,
which can facilitate microtubule polymerization. The LC2 C-
terminus is also capable of binding to microﬁlaments and ac-
tin. The association of MAP with actin may be regulated by
post-translational modiﬁcation, as the binding of MAP1B
heavy chain/light chain complex to actin requires prior treat-
ment with alkaline phosphatase [38], whereas phosphorylation
of MAP1B enhances binding to microtubules [46]. Similar
regulation of MAP1A association with actin and microtubules
has not been established, but may be important for the regu-
lation of the BKCa channel complex. The leucine-rich acidic
nuclear protein (LANP) interacts with the light chain of
MAP1B and modulates its eﬀects on neurite extension [47].
Similarly, caldendrin, a neuronal Ca2þ-sensor protein, associ-
ates with the microtubule cytoskeleton by binding to LC3 of
MAP1A/B [48].
Actin, the main component of the intracellular cytoskele-
ton, is believed to contribute to neurite growth and synapse
formation. Alteration in actin ﬁlaments has been shown to
regulate ion channel activity, such as the N-methyl-D-aspar-
tate channels [26], Naþ channels [49,50] and Kþ channels
[27,51]. Recent reports have also indicated that the actin
cytoskeleton can have profound eﬀects on the BKCa channel
in hippocampal neurons. For instance, disruption of the cy-
toskeleton after brief treatment with cytochalasin D markedly
decreased BKCa channel activity, characterized by shortened
open time and reduced open frequency. These ﬁndings sug-
gest that rat hippocampal CA1 pyridamidal neuron BKCa
channels can be directly modulated by dynamic assembly/
disassembly of submembranous actin cytoskeleton [28]. In
contrast, cytochalasin D increased BKCa channel activity in
rabbit coronary artery smooth muscle cells [28,29]. Our
ﬁndings demonstrate that the BKCa channel may associate
with the actin cytoskeleton through its interaction with the
light chain of MAP1A. This ﬁnding has important implica-
tions, as the actin cytoskeleton plays a critical role in the
regulation of cell shape, motility and participates in the tar-
geting of proteins to various cellular compartments. The
diﬀerential eﬀects of cytoskeleton modiﬁcation upon BKCa
channel activity in brain and smooth muscle [29] may be due
to diﬀerences in species, binding partners and/or b subunit
expression. Moreover, it has been shown that it plays an
important role in postsynaptic anchoring and the mainte-
nance of long-term potentiation. In addition to brain,
MAP1A is expressed in muscle and heart, which also express
BKCa channels [30]. Therefore, the BKCa-MAP1A associa-
tion found in brain may also be present in skeletal and car-
diac muscle. Whereas both actin ﬁlaments and microtubules
may mediate inhibition of smooth muscle BKCa channel
activity, only actin ﬁlaments are involved in the stretch sen-
sitivity of the BKCa channel [29]. Taken together, our ﬁnd-
ings that the BKCa channel can physically interact with the
actin cytoskeleton through direct binding with MAP1A,
along with electrophysiologic evidence that disruption of the
actin cytoskeleton leads to signiﬁcant changes in biophysical
properties of the channel [28,29] suggests a newly identiﬁed
intracellular signaling pathway impinging on the BKCa
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